Machine learning and multi-omics analyses reveal CLDN1 as a candidate marker associated with colorectal cancer invasion and nutlin-3a (−) response
Translational Oncology · 2026-12 · 74 · 103078
DOI: 10.1016/j.tranon.2026.103078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Oncology, 2026-12. Verfasst von Wenqi Shan und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, Henan, China. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Henan Provincial Science and Technology Research Project, Zhengzhou University, Key Research and Development Project of Hainan Province.
Abstract (Originalsprache)
OBJECTIVE: Colorectal cancer (CRC) is molecularly, cellularly and spatially heterogeneous, and current staging systems and biomarkers incompletely explain prognosis and treatment response. This study integrated transcriptomics, machine learning, single-cell RNA sequencing, spatial transcriptomics and in vitro experiments to prioritize candidate CRC-associated markers and characterize their potential biological and clinical relevance. METHODS: GSE44861 and GSE44076 from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas Colon Adenocarcinoma (TCGA-COAD) were used for differential expression, consensus differentially expressed gene (DEG) identification and functional enrichment analyses. Four machine-learning algorithms were applied for feature selection. Candidate genes were prioritized by differential expression, model importance and receiver operating characteristic (ROC) performance. GSE231559 single-cell data and spatial transcriptomics characterized the cellular source, pseudotime dynamics and spatial distribution of the core gene. TCGA-COAD assessed prognosis, pathways and computationally predicted drug sensitivity. Western blotting, Transwell and MTT assays were used for experimental validation, and public immunohistochemistry images from the Human Protein Atlas were used as supplementary protein-expression evidence. RESULTS: We identified 544 consensus DEGs enriched in leukocyte migration, chemotaxis, extracellular matrix organization, cytokine activity and metabolic pathways. Six genes were jointly selected: CLDN1, CDH3, KRT24, MMP7, NEBL and SCGN. CLDN1 was markedly upregulated and showed the highest tumour-versus-normal discrimination among the six candidates in the TCGA-COAD cohort. Single-cell and spatial analyses showed that CLDN1 was mainly expressed in CRC epithelial cells, displayed increasing expression across the inferred pseudotime ordering, and was enriched in malignant and mixed regions. In the TCGA-COAD cohort, high CLDN1 expression was associated with poorer overall survival and pathways involving the cell cycle, proteasome, autophagy, Hippo, ErbB and CRC. CLDN1 manipulation altered CRC-cell invasion and in vitro response to Nutlin-3a (-). CONCLUSION: These findings support CLDN1 as a candidate CRC-associated marker linked to malignant epithelial-cell states, tumour-associated spatial heterogeneity, invasive phenotype and Nutlin-3a (-) response. Further independent and prospective validation is required to determine its clinical diagnostic, prognostic and treatment-response relevance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, Henan, China.
- Department of Oncology, The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, Henan, China.
- Translational Medicine Research Center, The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, Henan, China.
- Scientific Research Management Office, The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, Henan, China.
- Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Department of Microbiology and Immunology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China. Electronic address: lnj717@zzu.edu.cn.
Förderung
- Henan Provincial Science and Technology Research Project
- Zhengzhou University
- Key Research and Development Project of Hainan Province
Zitieren
APA
Shan, W., Li, Q., Yuan, W., Feng, R., Hu, P., Song, Z., Li, Y., Luo, C., Lei, N., Zhang, H., & Wang, Z. (2026). Machine learning and multi-omics analyses reveal CLDN1 as a candidate marker associated with colorectal cancer invasion and nutlin-3a (−) response. Translational Oncology, 74, 103078. https://doi.org/10.1016/j.tranon.2026.103078
Vancouver
Shan W, Li Q, Yuan W, Feng R, Hu P, Song Z, et al. Machine learning and multi-omics analyses reveal CLDN1 as a candidate marker associated with colorectal cancer invasion and nutlin-3a (−) response. Translational Oncology. 2026;74:103078. doi:10.1016/j.tranon.2026.103078
BibTeX
@article{Shan2026,
author = {Shan, Wenqi and Li, Qianyu and Yuan, Wei and Feng, Ruiting and Hu, Peiyao and Song, Zongmian and Li, Yanfeng and Luo, Chenghan and Lei, Ningjing and Zhang, Haozhe and Wang, Zhaorui},
title = {Machine learning and multi-omics analyses reveal CLDN1 as a candidate marker associated with colorectal cancer invasion and nutlin-3a (−) response},
journal = {Translational Oncology},
year = {2026},
volume = {74},
pages = {103078},
doi = {10.1016/j.tranon.2026.103078}
}
EUVIMED